Literature DB >> 22159063

Radiation-induced myelopathy: treatment with bevacizumab.

Marc C Chamberlain1, Keith D Eaton, James Fink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22159063     DOI： 10.1001/archneurol.2011.621

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  4 in total

Review 1.  Radiotherapy-Specific Chronic Pain Syndromes in the Cancer Population: An Evidence-Based Narrative Review.

Authors:  Jay Karri; Laura Lachman; Alex Hanania; Anuj Marathe; Mani Singh; Nicholas Zacharias; Vwaire Orhurhu; Amitabh Gulati; Alaa Abd-Elsayed
Journal:  Adv Ther       Date:  2021-02-11       Impact factor: 3.845

Review 2.  Pathobiology of radiation myelopathy and strategies to mitigate injury.

Authors:  C S Wong; M G Fehlings; A Sahgal
Journal:  Spinal Cord       Date:  2015-03-24       Impact factor: 2.772

Review 3.  Radiation myelopathy following stereotactic body radiation therapy for spine metastases.

Authors:  Wee Loon Ong; Shun Wong; Hany Soliman; Sten Myrehaug; Chia-Lin Tseng; Jay Detsky; Zain Husain; Pejman Maralani; Lijun Ma; Simon S Lo; Arjun Sahgal
Journal:  J Neurooncol       Date:  2022-06-23       Impact factor: 4.506

4.  Radiation-Induced Myelitis: Initial and Follow-Up MRI and Clinical Features in Patients at a Single Tertiary Care Institution during 20 Years.

Authors:  M Khan; P Ambady; D Kimbrough; T Shoemaker; S Terezakis; J Blakeley; S D Newsome; I Izbudak
Journal:  AJNR Am J Neuroradiol       Date:  2018-05-17       Impact factor: 3.825
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.